610 related articles for article (PubMed ID: 28235058)
1. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
[TBL] [Abstract][Full Text] [Related]
2. The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.
Muhammed H; Misra DP; Jain N; Ganguly S; Pattanaik SS; Rai MK; Anuja AK; Mohindra N; Kumar S; Agarwal V
Clin Rheumatol; 2022 Dec; 41(12):3675-3686. PubMed ID: 36006556
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
5. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
6. Carotid Intima Media Thickness in Mainly Female HIV-Infected Subjects in Rural South Africa: Association With Cardiovascular but Not HIV-Related Factors.
Schoffelen AF; de Groot E; Tempelman HA; Visseren FL; Hoepelman AI; Barth RE
Clin Infect Dis; 2015 Nov; 61(10):1606-14. PubMed ID: 26215596
[TBL] [Abstract][Full Text] [Related]
7. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
Mosepele M; Hemphill LC; Moloi W; Moyo S; Nkele I; Makhema J; Bennett K; Triant VA; Lockman S
PLoS One; 2017; 12(6):e0179994. PubMed ID: 28662159
[TBL] [Abstract][Full Text] [Related]
8. The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
Ozen G; Sunbul M; Atagunduz P; Direskeneli H; Tigen K; Inanc N
Rheumatology (Oxford); 2016 Mar; 55(3):513-22. PubMed ID: 26472565
[TBL] [Abstract][Full Text] [Related]
9. Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa.
Nonterah EA; Boateng D; Crowther NJ; Klipstein-Grobusch K; Oduro AR; Agongo G; Mohamed SF; Boua PR; Choma SSR; Norris SA; Tollman SM; Bots ML; Ramsay M; Grobbee D
JAMA Netw Open; 2022 Apr; 5(4):e227559. PubMed ID: 35471573
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
[TBL] [Abstract][Full Text] [Related]
11. Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.
Chen S; Li N; Shen Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):966-973. PubMed ID: 34707006
[TBL] [Abstract][Full Text] [Related]
12. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
[TBL] [Abstract][Full Text] [Related]
13. Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.
Shen J; Lam SH; Shang Q; Wong CK; Li EK; Wong P; Kun EW; Cheng IT; Li M; Li TK; Zhu TY; Lee JJ; Chang M; Lee AP; Tam LS
J Rheumatol; 2018 Feb; 45(2):218-226. PubMed ID: 29142027
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease.
Ofori S; Dodiyi-Manuel S; Akpa MR
J Clin Lipidol; 2017; 11(6):1441-1447. PubMed ID: 29050979
[TBL] [Abstract][Full Text] [Related]
15. Prediction of future cardiovascular events by Framingham, SCORE and asCVD risk scores is less accurate in HIV-positive individuals from the HIV-HEART Study compared with the general population.
Schulz CA; Mavarani L; Reinsch N; Albayrak-Rena S; Potthoff A; Brockmeyer N; Hower M; Erbel R; Jöckel KH; Schmidt B; Esser S;
HIV Med; 2021 Sep; 22(8):732-741. PubMed ID: 34028959
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations.
Pirš M; Jug B; Eržen B; Šabović M; Karner P; Poljak M; Tomažič J
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(3):43-7. PubMed ID: 25242159
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Predicted Cardiovascular Risk Profiles by Different CVD Risk-Scoring Algorithms between HIV-1-Infected and Uninfected Adults: A Cross-Sectional Study in Tanzania.
Msoka T; Rogath J; Van Guilder G; Kapanda G; Smulders Y; Tutu van Furth M; Bartlett J; van Agtmael M
HIV AIDS (Auckl); 2021; 13():605-615. PubMed ID: 34113177
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
19. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study.
Imoh LC; Ani CC; Iyua KO; Odo AI; Amusa GA; Osaigbovo GO; Isichei CO; Agbaji OO; Imade G; Zoakah AI; Okeahialam BN; Sagay AS
Pan Afr Med J; 2020; 37():388. PubMed ID: 33796201
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
